# A Study of Pentasa in Patients With Ulcerative Colitis

> **NCT01104753** · — · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 338 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01104753
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-10
- **Final completion:** 2011-03
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2011-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104753, "A Study of Pentasa in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01104753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*